Lung Cancer in Women Who Never Smoked

Allan I. Fleming


Lindi Campbell, lung cancer advocate, Lexington, KY.

Alice Berger, PhD, assistant professor, Human Biology Division, Fred Hutchinson Cancer Research Center.

Ramaswamy Govindan, MD, professor of medicine (medical oncology); Anheuser Busch endowed chair in medical oncology, Washington University School of Medicine, St. Louis.

Joy Feliciano, MD, associate professor of oncology, Johns Hopkins University School of Medicine.

Roy Herbst, MD, PhD, Ensign professor of medicine (medical oncology) and professor of pharmacology, Yale School of Medicine; director, Center for Thoracic Cancers; chief of medical oncology, Yale Cancer Center and Smilow Cancer Hospital; associate cancer center director, translational science.

Missouri Medicine: “Lung Cancer in Non-Smokers.”

CDC: “National Center for Health Statistics — Glossary,” “Lung Cancer — Who Should Be Screened for Lung Cancer?”

Journal of Clinical Oncology: “Lung Cancer in Never Smokers: A Review,” “Genomic Profiling of Lung Adenocarcinoma in Never-Smokers.”

Memorial Sloan Kettering Cancer Center: “Lung Cancer Genomic Testing (EGFR, KRAS, ALK).”

American Cancer Society: “Facts & Figures 2021 Reports Another Record-Breaking 1-Year Drop in Cancer Deaths,” “Targeted Drug Therapy for Non-Small Cell Lung Cancer,” “Immunotherapy for Non-Small Cell Lung Cancer.”

American Lung Association: “New Report: Kentucky Has Highest Lung Cancer Rates in the Nation, Bottom of List in Survival, Early Diagnosis.”

People: “Dana Reeve Brave to the End.”

Next Post

The Theranos Trial: What You Should Know

Oct. 25, 2021 — The promise seemed too good to be true: Walk into your local drugstore, provide a few drops of blood via finger-prick, and get screened for hundreds of different diseases, quickly and cheaply. That’s what Silicon Valley startup Theranos, founded by Elizabeth Holmes, touted. As it turned […]